Thrombolytic Science
Biotechnology
Cambridge, Ma, United States
4 employees
- Employees
- 4
Thrombolytic Science Overview
- Headquarters
- Cambridge, Ma, United States
- Phone Number
- Available in AeroLeads
- Website
- tsillc.net
- Industry
- Biotechnology
- Employees
- 4
- Founded
- 2006
- Funding
- 7.5M
- Company Email
- Available in AeroLeads
About Thrombolytic Science
TSI is a privately-held vascular medicine and biotechnology company currently developing a new-generation clot-dissolving therapy with the first novel mechanism of action in 20 years for stroke and other thrombotic diseases. TSI’s technology is based upon pioneering earlier work on pro-urokinase (proUK) by its cofounders. The primary component of TSI’s thrombolytic therapy is a rationally designed mutant of proUK.
Thrombolytic Science Contact Details
- People in AeroLeads
- 1
Thrombolytic Science Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Alexis C. Wallace | President & CEO, Co-founder & Board |
View
|
Employees by Management Level
Individual contributor
2 profiles
Executive
1 profile
Department Contact Coverage
| Department | Contacts | Phone | |
|---|---|---|---|
| Healthcare | 1 | 1 | 0 |
Thrombolytic Science Tech Stack
Compare Similar Companies to Thrombolytic Science
Verve Therapeutics
Biotechnology Research
Vaxess Technologies
Pharmaceutical Manufacturing
Walden Biosciences
Biotechnology Research
Ventum Biotech
Biotechnology Research
Tauriga Sciences Inc (OTCQB: TAUG)
Biotechnology
Triform Sciences LLC
Pharmaceutical Manufacturing
Whitelaw Compliance Group, LLC.
Legal Services
Targeted Pharmaceuticals
Pharmaceutical Manufacturing
Tranquility Labs
Pharmaceutical Manufacturing
VIAVI labs
Pharmaceutical Manufacturing